Myeloma Novel Drug Targets and agents
Dual targeting of the RAS-MAPK pathway as a personized medicine approach in RASMut multiple myeloma
Josefine Krüger, MD
Physician
Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany, Germany